Sustainability & Climate

Bel Group's massive $200M investment in its South Dakota Babybel plant will double production, add 150 jobs, and capitalize on America's new snacking habits.

A new partnership aims to bring institutional-grade defined outcome strategies to the masses, blending ETFs and structured notes to deliver buffered protection.

The deal with Ahngook Pharm for its GMRx2 single-pill therapy marks a key step in a global strategy validated by recent US FDA approval.

Renter network Stake lands $8M and buys UMoveFree, creating an end-to-end AI platform that puts cash back into renters' pockets from search to signing.

A new report says 10 advanced reactors could add $1T to the U.S. economy, but past project failures and major workforce hurdles cast a long shadow.

A landmark study reveals a new test can predict and help prevent premature births in low-risk pregnancies, with a Texas hospital playing a leading role.

As palates shift, Washington's Tieton Cider Works leverages its farm-to-bottle roots and rapid growth to launch a bone-dry cider for modern purists.

Fueled by a relentless acquisition strategy and 13% organic growth, Turpaz Industries' 2025 results vastly outpace rivals, setting a new industry benchmark.

New PE firm Agellus Capital's investment in Titan Restoration signals a strategic push into the resilient property services sector, fueling national expansion.

A new study validating patient-reported outcomes in HAE is set to standardize clinical trials, strengthening the case for new oral therapies like deucrictibant.

Global giant SOCOTEC continues its rapid U.S. expansion by acquiring American Engineers Group, gaining a strategic foothold in the critical Mid-Atlantic market.

A pioneering project in Spain will use novel electrolysis to make green hydrogen from solar alone, aiming to slash costs and boost Europe's energy security.

With a fresh $500M, Quince's factory-direct model challenges retail giants by promising luxury quality without the traditional markup. Is this the future?

The UK's fitness landscape is being reshaped. New data reveals a surge in niche sports like Pilates and a boom in independent fitness entrepreneurs.

China's 'Lighting Capital' launches a bold new strategy, inviting 100+ major overseas buyers to its 34th fair to deepen global trade ties.

Advocates call for colorectal cancer screening to start at 45 as cases surge in people under 50, raising questions about Canada's readiness.

A new framework aims to bridge the gap between open-source software and strict safety standards, potentially revolutionizing industries from auto to medical.

As automation demand soars, ATS Corp. will meet investors to outline its strategy for navigating market shifts and capitalizing on life sciences growth.

With a strong cash position and new leadership, Artiva pivots its AlloNK® cell therapy to autoimmune disease, targeting a pivotal trial for RA in 2026.

A minor schedule change for Columbus McKinnon's key investor presentation hints at a pivotal moment for the intelligent motion solutions giant. Here's the story.